{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Grade 3-4 acute Graft-Versus-Host Disease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}],"title":"Grade 3-4 mucositis"}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"groups":[{"description":"Conditioning with Alemtuzumab, busulfan and fludarabine followed by allogeneic hematopoietic cell transplant.","id":"OG000","title":"Single Arm"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 year post-transplantation","title":"Toxicity Grade ≥ 3 From Start of Conditioning Through the First Year Post Transplantation","type":"SECONDARY","unitOfMeasure":"participants"}